1. Home
  2. Pharma & Healthcare
  3. Global Denosumab Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Denosumab Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Publication Month: Feb 2023 | No. of Pages: 60 Published By: Global Info Research
Single User License: US $ 3480
Corporate User License: US $ 6960

According to our (Global Info Research) latest study, the global Denosumab market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Denosumab market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Denosumab market size and forecasts, in consumption value ($ Million), 2018-2029
Global Denosumab market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Denosumab market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Denosumab market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Denosumab
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Denosumab market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Qilu Pharmaceutical, Shandong Boan Biotech and Shanghai Mabwell, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Denosumab market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
60 mg
120 mg
Market segment by Application
Hospital
Clinic
Others
Market segment by players, this report covers
Amgen
Qilu Pharmaceutical
Shandong Boan Biotech
Shanghai Mabwell
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Denosumab product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Denosumab, with revenue, gross margin and global market share of Denosumab from 2018 to 2023.
Chapter 3, the Denosumab competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Denosumab market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Denosumab.
Chapter 13, to describe Denosumab research findings and conclusion.

1 Market Overview
1.1 Product Overview and Scope of Denosumab
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Denosumab by Type
1.3.1 Overview: Global Denosumab Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Denosumab Consumption Value Market Share by Type in 2022
1.3.3 60 mg
1.3.4 120 mg
1.4 Global Denosumab Market by Application
1.4.1 Overview: Global Denosumab Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Denosumab Market Size & Forecast
1.6 Global Denosumab Market Size and Forecast by Region
1.6.1 Global Denosumab Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Denosumab Market Size by Region, (2018-2029)
1.6.3 North America Denosumab Market Size and Prospect (2018-2029)
1.6.4 Europe Denosumab Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Denosumab Market Size and Prospect (2018-2029)
1.6.6 South America Denosumab Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Denosumab Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Denosumab Product and Solutions
2.1.4 Amgen Denosumab Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Amgen Recent Developments and Future Plans
2.2 Qilu Pharmaceutical
2.2.1 Qilu Pharmaceutical Details
2.2.2 Qilu Pharmaceutical Major Business
2.2.3 Qilu Pharmaceutical Denosumab Product and Solutions
2.2.4 Qilu Pharmaceutical Denosumab Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Qilu Pharmaceutical Recent Developments and Future Plans
2.3 Shandong Boan Biotech
2.3.1 Shandong Boan Biotech Details
2.3.2 Shandong Boan Biotech Major Business
2.3.3 Shandong Boan Biotech Denosumab Product and Solutions
2.3.4 Shandong Boan Biotech Denosumab Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Shandong Boan Biotech Recent Developments and Future Plans
2.4 Shanghai Mabwell
2.4.1 Shanghai Mabwell Details
2.4.2 Shanghai Mabwell Major Business
2.4.3 Shanghai Mabwell Denosumab Product and Solutions
2.4.4 Shanghai Mabwell Denosumab Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Shanghai Mabwell Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Denosumab Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Denosumab by Company Revenue
3.2.2 Top 3 Denosumab Players Market Share in 2022
3.2.3 Top 6 Denosumab Players Market Share in 2022
3.3 Denosumab Market: Overall Company Footprint Analysis
3.3.1 Denosumab Market: Region Footprint
3.3.2 Denosumab Market: Company Product Type Footprint
3.3.3 Denosumab Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Denosumab Consumption Value and Market Share by Type (2018-2023)
4.2 Global Denosumab Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Denosumab Consumption Value Market Share by Application (2018-2023)
5.2 Global Denosumab Market Forecast by Application (2024-2029)
6 North America
6.1 North America Denosumab Consumption Value by Type (2018-2029)
6.2 North America Denosumab Consumption Value by Application (2018-2029)
6.3 North America Denosumab Market Size by Country
6.3.1 North America Denosumab Consumption Value by Country (2018-2029)
6.3.2 United States Denosumab Market Size and Forecast (2018-2029)
6.3.3 Canada Denosumab Market Size and Forecast (2018-2029)
6.3.4 Mexico Denosumab Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Denosumab Consumption Value by Type (2018-2029)
7.2 Europe Denosumab Consumption Value by Application (2018-2029)
7.3 Europe Denosumab Market Size by Country
7.3.1 Europe Denosumab Consumption Value by Country (2018-2029)
7.3.2 Germany Denosumab Market Size and Forecast (2018-2029)
7.3.3 France Denosumab Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Denosumab Market Size and Forecast (2018-2029)
7.3.5 Russia Denosumab Market Size and Forecast (2018-2029)
7.3.6 Italy Denosumab Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Denosumab Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Denosumab Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Denosumab Market Size by Region
8.3.1 Asia-Pacific Denosumab Consumption Value by Region (2018-2029)
8.3.2 China Denosumab Market Size and Forecast (2018-2029)
8.3.3 Japan Denosumab Market Size and Forecast (2018-2029)
8.3.4 South Korea Denosumab Market Size and Forecast (2018-2029)
8.3.5 India Denosumab Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Denosumab Market Size and Forecast (2018-2029)
8.3.7 Australia Denosumab Market Size and Forecast (2018-2029)
9 South America
9.1 South America Denosumab Consumption Value by Type (2018-2029)
9.2 South America Denosumab Consumption Value by Application (2018-2029)
9.3 South America Denosumab Market Size by Country
9.3.1 South America Denosumab Consumption Value by Country (2018-2029)
9.3.2 Brazil Denosumab Market Size and Forecast (2018-2029)
9.3.3 Argentina Denosumab Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Denosumab Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Denosumab Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Denosumab Market Size by Country
10.3.1 Middle East & Africa Denosumab Consumption Value by Country (2018-2029)
10.3.2 Turkey Denosumab Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Denosumab Market Size and Forecast (2018-2029)
10.3.4 UAE Denosumab Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Denosumab Market Drivers
11.2 Denosumab Market Restraints
11.3 Denosumab Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Denosumab Industry Chain
12.2 Denosumab Upstream Analysis
12.3 Denosumab Midstream Analysis
12.4 Denosumab Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Tables and Figures

List of Tables
Table 1. Global Denosumab Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Denosumab Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Denosumab Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Denosumab Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Amgen Company Information, Head Office, and Major Competitors
Table 6. Amgen Major Business
Table 7. Amgen Denosumab Product and Solutions
Table 8. Amgen Denosumab Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Amgen Recent Developments and Future Plans
Table 10. Qilu Pharmaceutical Company Information, Head Office, and Major Competitors
Table 11. Qilu Pharmaceutical Major Business
Table 12. Qilu Pharmaceutical Denosumab Product and Solutions
Table 13. Qilu Pharmaceutical Denosumab Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Qilu Pharmaceutical Recent Developments and Future Plans
Table 15. Shandong Boan Biotech Company Information, Head Office, and Major Competitors
Table 16. Shandong Boan Biotech Major Business
Table 17. Shandong Boan Biotech Denosumab Product and Solutions
Table 18. Shandong Boan Biotech Denosumab Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Shandong Boan Biotech Recent Developments and Future Plans
Table 20. Shanghai Mabwell Company Information, Head Office, and Major Competitors
Table 21. Shanghai Mabwell Major Business
Table 22. Shanghai Mabwell Denosumab Product and Solutions
Table 23. Shanghai Mabwell Denosumab Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Shanghai Mabwell Recent Developments and Future Plans
Table 25. Global Denosumab Revenue (USD Million) by Players (2018-2023)
Table 26. Global Denosumab Revenue Share by Players (2018-2023)
Table 27. Breakdown of Denosumab by Company Type (Tier 1, Tier 2, and Tier 3)
Table 28. Market Position of Players in Denosumab, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 29. Head Office of Key Denosumab Players
Table 30. Denosumab Market: Company Product Type Footprint
Table 31. Denosumab Market: Company Product Application Footprint
Table 32. Denosumab New Market Entrants and Barriers to Market Entry
Table 33. Denosumab Mergers, Acquisition, Agreements, and Collaborations
Table 34. Global Denosumab Consumption Value (USD Million) by Type (2018-2023)
Table 35. Global Denosumab Consumption Value Share by Type (2018-2023)
Table 36. Global Denosumab Consumption Value Forecast by Type (2024-2029)
Table 37. Global Denosumab Consumption Value by Application (2018-2023)
Table 38. Global Denosumab Consumption Value Forecast by Application (2024-2029)
Table 39. North America Denosumab Consumption Value by Type (2018-2023) & (USD Million)
Table 40. North America Denosumab Consumption Value by Type (2024-2029) & (USD Million)
Table 41. North America Denosumab Consumption Value by Application (2018-2023) & (USD Million)
Table 42. North America Denosumab Consumption Value by Application (2024-2029) & (USD Million)
Table 43. North America Denosumab Consumption Value by Country (2018-2023) & (USD Million)
Table 44. North America Denosumab Consumption Value by Country (2024-2029) & (USD Million)
Table 45. Europe Denosumab Consumption Value by Type (2018-2023) & (USD Million)
Table 46. Europe Denosumab Consumption Value by Type (2024-2029) & (USD Million)
Table 47. Europe Denosumab Consumption Value by Application (2018-2023) & (USD Million)
Table 48. Europe Denosumab Consumption Value by Application (2024-2029) & (USD Million)
Table 49. Europe Denosumab Consumption Value by Country (2018-2023) & (USD Million)
Table 50. Europe Denosumab Consumption Value by Country (2024-2029) & (USD Million)
Table 51. Asia-Pacific Denosumab Consumption Value by Type (2018-2023) & (USD Million)
Table 52. Asia-Pacific Denosumab Consumption Value by Type (2024-2029) & (USD Million)
Table 53. Asia-Pacific Denosumab Consumption Value by Application (2018-2023) & (USD Million)
Table 54. Asia-Pacific Denosumab Consumption Value by Application (2024-2029) & (USD Million)
Table 55. Asia-Pacific Denosumab Consumption Value by Region (2018-2023) & (USD Million)
Table 56. Asia-Pacific Denosumab Consumption Value by Region (2024-2029) & (USD Million)
Table 57. South America Denosumab Consumption Value by Type (2018-2023) & (USD Million)
Table 58. South America Denosumab Consumption Value by Type (2024-2029) & (USD Million)
Table 59. South America Denosumab Consumption Value by Application (2018-2023) & (USD Million)
Table 60. South America Denosumab Consumption Value by Application (2024-2029) & (USD Million)
Table 61. South America Denosumab Consumption Value by Country (2018-2023) & (USD Million)
Table 62. South America Denosumab Consumption Value by Country (2024-2029) & (USD Million)
Table 63. Middle East & Africa Denosumab Consumption Value by Type (2018-2023) & (USD Million)
Table 64. Middle East & Africa Denosumab Consumption Value by Type (2024-2029) & (USD Million)
Table 65. Middle East & Africa Denosumab Consumption Value by Application (2018-2023) & (USD Million)
Table 66. Middle East & Africa Denosumab Consumption Value by Application (2024-2029) & (USD Million)
Table 67. Middle East & Africa Denosumab Consumption Value by Country (2018-2023) & (USD Million)
Table 68. Middle East & Africa Denosumab Consumption Value by Country (2024-2029) & (USD Million)
Table 69. Denosumab Raw Material
Table 70. Key Suppliers of Denosumab Raw Materials
List of Figures
Figure 1. Denosumab Picture
Figure 2. Global Denosumab Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Denosumab Consumption Value Market Share by Type in 2022
Figure 4. 60 mg
Figure 5. 120 mg
Figure 6. Global Denosumab Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Denosumab Consumption Value Market Share by Application in 2022
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Others Picture
Figure 11. Global Denosumab Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Denosumab Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Denosumab Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Denosumab Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Denosumab Consumption Value Market Share by Region in 2022
Figure 16. North America Denosumab Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Denosumab Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Denosumab Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Denosumab Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Denosumab Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Denosumab Revenue Share by Players in 2022
Figure 22. Denosumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Denosumab Market Share in 2022
Figure 24. Global Top 6 Players Denosumab Market Share in 2022
Figure 25. Global Denosumab Consumption Value Share by Type (2018-2023)
Figure 26. Global Denosumab Market Share Forecast by Type (2024-2029)
Figure 27. Global Denosumab Consumption Value Share by Application (2018-2023)
Figure 28. Global Denosumab Market Share Forecast by Application (2024-2029)
Figure 29. North America Denosumab Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Denosumab Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Denosumab Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Denosumab Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Denosumab Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Denosumab Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Denosumab Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Denosumab Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Denosumab Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Denosumab Consumption Value (2018-2029) & (USD Million)
Figure 39. France Denosumab Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Denosumab Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Denosumab Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Denosumab Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Denosumab Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Denosumab Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Denosumab Consumption Value Market Share by Region (2018-2029)
Figure 46. China Denosumab Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Denosumab Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Denosumab Consumption Value (2018-2029) & (USD Million)
Figure 49. India Denosumab Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Denosumab Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Denosumab Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Denosumab Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Denosumab Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Denosumab Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Denosumab Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Denosumab Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Denosumab Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Denosumab Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Denosumab Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Denosumab Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Denosumab Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Denosumab Consumption Value (2018-2029) & (USD Million)
Figure 63. Denosumab Market Drivers
Figure 64. Denosumab Market Restraints
Figure 65. Denosumab Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Denosumab in 2022
Figure 68. Manufacturing Process Analysis of Denosumab
Figure 69. Denosumab Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source




Companies Mentioned
Amgen
Qilu Pharmaceutical
Shandong Boan Biotech
Shanghai Mabwell

Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets